West Paces Advisors’s Quest Diagnostics DGX Stock Holding History

West Paces Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$13.5K	Sell	58 -11	-16%	-$2.54K	﹤0.01%	378
2026 Q2	$14.6K	Buy	+69	New	+$13.5K	﹤0.01%	365
2025 Q2	–	Sell	-72	Closed	-$12.2K	–	302
2025 Q1	$12.2K	Hold	72	–	–	﹤0.01%	330
2024 Q4	$10.9K	Hold	72	–	–	﹤0.01%	342
2024 Q3	$11.2K	Hold	72	–	–	﹤0.01%	342
2024 Q2	$9.9K	Hold	72	–	–	﹤0.01%	353
2024 Q1	$9.6K	Sell	72 -2	-3%	-$259	﹤0.01%	364
2023 Q4	$10.2K	Buy	74 +16	+28%	+$2.1K	﹤0.01%	359
2023 Q3	$7.07K	Hold	58	–	–	﹤0.01%	371
2023 Q2	$8.15K	Hold	58	–	–	﹤0.01%	386
2023 Q1	$8.21K	Hold	58	–	–	﹤0.01%	384
2022 Q4	$9.07K	Hold	58	–	–	﹤0.01%	360
2022 Q3	$7.12K	Hold	58	–	–	﹤0.01%	368
2022 Q2	$7.71K	Hold	58	–	–	﹤0.01%	385
2022 Q1	$7.94K	Hold	58	–	–	﹤0.01%	382
2021 Q4	$10K	Hold	58	–	–	﹤0.01%	374
2021 Q3	$8.43K	Hold	58	–	–	﹤0.01%	372
2021 Q2	$7.65K	Hold	58	–	–	﹤0.01%	383
2021 Q1	$7.44K	Buy	+58	New	+$7.15K	﹤0.01%	358
2017 Q3	–	Sell	-2	Closed	-$222	–	480
2017 Q2	$222	Hold	2	–	–	﹤0.01%	497
2017 Q1	$196	Hold	2	–	–	﹤0.01%	497
2016 Q4	$184	Buy	+2	New	+$172	﹤0.01%	549

Other funds holding DGX

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

M&G plc London, United Kingdom $19.9B AUM 15.09% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

West Paces Advisors's DGX Position: Q3 2026 in Review

West Paces Advisors reduced its Quest Diagnostics (DGX) stake by 16% in Q3 2026, selling an estimated $2.54K and leaving 58 shares worth $13.5K. The position accounts for ﹤0.01% of the portfolio, ranked #378.

West Paces Advisors first reported a position in DGX in Q4 2016 and has held it in 22 quarters since. The position peaked at $14.6K in Q2 2026. 566 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

West Paces Advisors held 58 shares of Quest Diagnostics worth $13.5K as of Q3 2026.
West Paces Advisors sold 11 Quest Diagnostics shares in Q3 2026, an estimated $2.54K.
Quest Diagnostics made up ﹤0.01% of West Paces Advisors's portfolio in Q3 2026, its #378 holding.
West Paces Advisors first reported a position in Quest Diagnostics in Q4 2016 and has held it in 22 quarters since.
West Paces Advisors's Quest Diagnostics position peaked at $14.6K in Q2 2026.
566 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on West Paces Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.